Loading...
Images of Andrew Ayscough
(0 from 0 )News
Evotec to Collaborate With Takeda Cambridge for Multi-Target Hit...
pipelinereview.com
Evotec to Collaborate With Takeda Cambridge for Multi-Target Hit Identification
News & Updates — Richman Chemical Inc. | Custom Synthesis | Toll...
www.richmanchemical.com
Richman Chemical's newsletters, press releases, and other updates.
Evotec to Collaborate With Takeda Cambridge for
www.globenewswire.com
Dr Andrew Ayscough, Director of Chemistry at Takeda Cambridge, commented: "We are pleased to have this opportunity to work with Evotec making use of their hit identification platform."
finanzen.net - Seite nicht gefunden
www.finanzen.net
TR ONE-News: Evotec AG | Nachricht | finanzen.net
sorted by relevance / date